Published in Ann Surg on October 01, 2009
Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg (2013) 2.36
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28
Liver planning software accurately predicts postoperative liver volume and measures early regeneration. J Am Coll Surg (2014) 2.19
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59
Definition of Readmission in 3,041 Patients Undergoing Hepatectomy. J Am Coll Surg (2015) 1.48
Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford) (2011) 1.44
Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg (2012) 1.17
Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections. J Gastrointest Surg (2012) 1.14
Role of surgery in colorectal cancer liver metastases. World J Gastroenterol (2014) 1.13
Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol (2013) 1.05
Prospective volumetric assessment of the liver on a personal computer by nonradiologists prior to partial hepatectomy. World J Surg (2011) 1.04
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg (2012) 1.02
Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol (2014) 0.97
Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am (2014) 0.95
Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg (2014) 0.91
Liver function following extended hepatectomy can be accurately predicted using remnant liver volume to body weight ratio. World J Surg (2015) 0.90
Little girl who conquered the "ALPPS''. World J Gastroenterol (2014) 0.88
Kinetics of liver function tests after a hepatectomy for colorectal liver metastases predict post-operative liver failure as defined by the International Study Group for Liver Surgery. HPB (Oxford) (2012) 0.88
Assessment of the reporting of quality and outcome measures in hepatic resections: a call for 90-day reporting in all hepatectomy series. HPB (Oxford) (2015) 0.86
A comparison of right posterior sectorectomy with formal right hepatectomy: a dual-institution study. HPB (Oxford) (2013) 0.85
Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol (2015) 0.85
Early post-operative prediction of morbidity and mortality after a major liver resection for colorectal metastases. HPB (Oxford) (2012) 0.85
Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. Semin Oncol (2010) 0.84
Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery. HPB (Oxford) (2015) 0.84
Pretreatment assessment of hepatocellular cancer: expert consensus conference. HPB (Oxford) (2010) 0.83
Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC. Int J Hepatol (2011) 0.82
Patient selection for hepatic resection for metastatic colorectal cancer. J Gastrointest Oncol (2012) 0.82
Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol (2012) 0.82
Liver Transplantation for HCC: A Review. Indian J Surg (2011) 0.82
Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure. HPB (Oxford) (2014) 0.82
One-stage hepatectomy following portal vein embolization for colorectal liver metastasis. World J Surg (2013) 0.82
Update in management of hepatocellular carcinoma in Eastern population. World J Hepatol (2015) 0.81
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2012) 0.80
Impact of future remnant liver volume on post-hepatectomy regeneration in non-cirrhotic livers. Front Surg (2014) 0.80
Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma. World J Hepatol (2015) 0.80
Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. J Am Coll Surg (2014) 0.79
Is computed tomography volumetric assessment of the liver reliable in patients with cirrhosis? HPB (Oxford) (2013) 0.79
Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection. Int J Mol Med (2010) 0.79
Are two-stage hepatectomies associated with more complications than one-stage procedures? HPB (Oxford) (2012) 0.79
Inferior right hepatic vein-preserving major right hepatectomy for hepatocellular carcinoma in patients with significant fibrosis or cirrhosis. World J Surg (2014) 0.79
Metabolic syndrome and hepatic resection: improving outcome. HPB (Oxford) (2011) 0.78
Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy. HPB (Oxford) (2011) 0.78
Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial. J Gastroenterol (2015) 0.78
Post-hepatectomy liver failure in patients with colorectal liver metastases. Surg Today (2015) 0.78
Indications, limitations and maneuvers to enable extended hepatectomy: current trends. World J Gastroenterol (2014) 0.78
Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease. Curr Colorectal Cancer Rep (2015) 0.78
Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection. Korean J Hepatobiliary Pancreat Surg (2013) 0.77
Issues in surgery for hilar cholangiocarcinoma. Indian J Surg (2011) 0.77
Three-dimensional CT volumetry predicts outcome of laparoscopic splenectomy for splenomegaly: retrospective clinical study. World J Surg (2013) 0.77
Assessment of Liver Remnant Using ICG Clearance Intraoperatively during Vascular Exclusion: Early Experience with the ALIIVE Technique. HPB Surg (2015) 0.77
Prolonged portal triad clamping increases postoperative sepsis after major hepatectomy in patients with sinusoidal obstruction syndrome and/or steatohepatitis. World J Surg (2012) 0.77
Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases. World J Surg Oncol (2013) 0.77
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma. Adv Ther (2016) 0.76
Liver angulometry: a simple method to estimate liver volume and ratios. HPB (Oxford) (2013) 0.76
Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies. HPB (Oxford) (2012) 0.76
Surgical approach for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol (2015) 0.76
Changes in Liver Volume in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy. J Clin Exp Hepatol (2015) 0.75
Re "Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections". HPB (Oxford) (2016) 0.75
Liver regeneration after liver resection: clinical aspects and correlation with infective complications. World J Gastroenterol (2014) 0.75
Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein. World J Gastroenterol (2016) 0.75
Identification of liver metastases with probe-based confocal laser endomicroscopy at two excitation wavelengths. Lasers Surg Med (2016) 0.75
Delayed diagnosis of alpha-1-antitrypsin deficiency following post-hepatectomy liver failure: A case report. World J Gastroenterol (2016) 0.75
Risk Factors Associated with Increased Morbidity in Living Liver Donation. J Transplant (2015) 0.75
Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report. Surg Case Rep (2016) 0.75
ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases. World J Surg Oncol (2017) 0.75
Major hepatic resection: from volumetry to liver scintigraphy. HPB (Oxford) (2016) 0.75
Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions. Cancer Biol Med (2016) 0.75
Assessment of Volumetric versus Manual Measurement in Disseminated Testicular Cancer; No Difference in Assessment between Non-Radiologists and Genitourinary Radiologist. PLoS One (2017) 0.75
Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis. HPB (Oxford) (2016) 0.75
Other non-surgical treatments for liver cancer. Rep Pract Oncol Radiother (2017) 0.75
Ventral segment-preserving right hepatectomy in patients with hepatocellular carcinoma. World J Surg (2015) 0.75
Portal vein embolization in extended liver resection. Langenbecks Arch Surg (2017) 0.75
Hypertrophy of the Left Liver in Patients with Large Tumors in the Right Liver. World J Surg (2015) 0.75
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 15.05
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol (2009) 5.42
The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol (2008) 4.37
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 4.34
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (2007) 4.09
Simplified staging for hepatocellular carcinoma. J Clin Oncol (2002) 3.48
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 3.45
Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol (2007) 3.45
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg (2008) 3.36
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.96
Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci U S A (2006) 2.91
Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol (2003) 2.85
Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer (2007) 2.83
Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg (2004) 2.62
Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg (2002) 2.62
Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg (2007) 2.62
Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol (2008) 2.52
Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma. Cancer Biol Ther (2006) 2.45
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43
Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol (2007) 2.40
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol (2005) 2.38
Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg (2013) 2.36
Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28
Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol (2009) 2.27
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol (2007) 2.26
Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21
Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg (2003) 2.20
Modified Makuuchi incision for foregut procedures. Arch Surg (2010) 2.15
Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev (2009) 2.12
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer (2007) 2.12
Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol (2006) 2.12
Solitary colorectal liver metastasis: resection determines outcome. Arch Surg (2006) 2.06
Management of TIPS-related refractory hepatic encephalopathy with reduced Wallgraft endoprostheses. J Vasc Interv Radiol (2003) 2.05
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer (2010) 2.04
Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg (2003) 2.03
Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer (2002) 2.03
The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol (2008) 2.02
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J (2003) 2.02
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer (2012) 2.01
Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg (2004) 2.01
Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg (2004) 1.99
C-arm cone-beam CT: general principles and technical considerations for use in interventional radiology. J Vasc Interv Radiol (2008) 1.96
Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol (2005) 1.94